BISTTRY14:36Live
AGESA Price Target 2026AgeSA Hayat ve Emeklilik A.Ş.
- Volume
- TRY 38.9M
- Day range
- 194.20 – 201.90
- Previous close
- 199.50
- Market cap
- TRY 36.3B
Last updated: Source: Borsa Istanbul, 15-minute delayed
The average price target of 6 brokers for AGESA is TRY 367.06 (October 27, 2026), implying 82.07% from the last price.
Broker price targets, buy-hold-sell ratings and model portfolio status for AgeSA Hayat ve Emeklilik A.Ş. (AGESA). The average target is compared with the current price to derive the implied upside; the AI fair value estimate is shown for comparison.
Last updated: Source: Broker research
Analyst Consensus
- Average target
- 367.06 TL
- Median target
- 371.70 TL
- Highest target
- 412.30 TL
- Lowest target
- 300.00 TL
- Upside
- 82.07%
- Buy / Hold / Sell
- 5 / 0 / 0
Broker Price Targets
| Broker | Date | Rating | Target price | Upside |
|---|---|---|---|---|
 İş Yatırım | October 27, 2026 | Buy | 397.50 | 97.17% |
 Yapı Kredi | October 27, 2026 | Buy | 300.00 | 48.81% |
 Deniz | October 27, 2026 | Buy | 366.00 | 81.55% |
 Gedik | October 19, 2026 | Outperform | 349.13 | 73.18% |
 Phillipcapital | August 6, 2026 | ÖNERİ YOK | 412.30 | 104.51% |
 Oyak | August 4, 2026 | Outperform | 377.40 | 87.20% |
 Marbas | December 5, 2025 | Buy | 269.79 | — |
AI Fair Value
- AI fair value
- 252.11 TL
- Upside
- 25.05%
- Model date
- July 21, 2026
Frequently Asked Questions
How many brokers have a price target for AGESA?
6 brokers have an average target of TRY 367.06 for AGESA, with 5 buy, 0 hold and 0 sell ratings.
What are the highest and lowest price targets for AGESA?
The highest price target for AGESA is TRY 412.30, the lowest is TRY 300.00 and the median is TRY 371.70.
What is the AI price target for AGESA?
Our AI fair value model estimates TRY 252.11 for AGESA, a difference of 25.05% from the current price. The model was updated on July 21, 2026. Not investment advice.
Is a price target investment advice?
No. Price targets are opinions from broker research reports, provided for information only, not a recommendation to buy or sell.